Profile Picture
Rewards
  • Search
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
    • Real Estate
    • My Bing
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Calls Swift 'Kelce's wife'
Dropped by 18 brands
Named Browns starting QB
Priest stabbed to death
‘I am insecure’
Horse killed, 4 hurt in crash
To start military service
Sea monster's skull found
US F-16 jet crashes in SK
Receives $5B+ buyout offer?
Kids accept Nobel Prize
$43M+ overseas debut
Tanks enter Khan Younis
Suffers right hand fracture
To invest $1.5B in GoTo
Has non-Hodgkin's lymphoma
Stephanie Pope as new COO
Needs $46B for aid in '24
Stabbing at DC jail injures 3
Netanyahu speaks to Putin
Defamation suit goes to trial
AU to cut migrant intake
Bills beat Chiefs 20-17
Rangers beat Kings 4-1
1-year, $4 million deal
James makes USC debut
UK sends 2 minehunters
Cardi B confirms split
Capitals defeat Blackhawks
Teases ‘White Lotus’ S3
Attends Milei's inauguration
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
272,000 results
6d
Alzheimer's Disease Drug Development: Another Lost Year
Investing in most current Alzheimer's drug companies is not recommended because they are not likely to modify the disease.
Medical Xpress21d
New Alzheimer's drug shines light on need for assessments to head off 'a tsunami of cognitive afflictions'
Medicare will cover new class of Alzheimer's drugs if fully approved by FDA, with limits Jun 2, 2023 The real costs of the new Alzheimer's drug, most of which will fall to taxpayers Aug 14, 2023 ...
1don MSN
Anti-aging drug for dogs from San Francisco firm moves closer to gaining FDA approval
A drug that could potentially extend the life of large-breed dogs is closer to being approved by the FDA. Veterinarians ...
2don MSN
‘Monumental’: FDA approves first CRISPR-based gene-editing drug, marking breakthrough for sickle cell disease
Casgevy was developed by Boston-based Vertex Pharmaceuticals and CRISPR Therapeutics, which is headquartered in Zug, ...
Hosted on MSN18d
Wake Forest and Duke University holding clinical trials for an FDA-approved drug to prevent Alzheimer's
Two North Carolina universities are conducting clinical trials involving a Food and Drug Administration-approved drug for Alzheimer’s, and they need volunteers to test it out. The new AHEAD ...
3h
InMed's (NASDAQ: INM) Latest Research Demonstrates Potential In Treating Alzheimer's With A Rare Cannabinoid Analog
When it comes to treating degenerative diseases like Alzheimer’s, much of the current focus is on addressing the symptoms ...
13d
What To Know About Metformin: The Decades-Old Diabetes Drug Fueling Billions in Longevity Research
American mortality is at the youngest it has been in almost two decades. But could repurposing a decades-old diabetes drug ...
Yahoo News11d
New research on a drug to fight against Alzheimer’s
COLUMBUS, Ohio (WCMH) – Just four months after the Food and Drug Administration gave full approval to a new Alzheimer’s drug, it’s estimated that tens of thousands of patients in the initial stages of ...
Yahoo Finance23d
FDA commissioner talks on the review process for drugs
From weight loss drugs that continue to roll out to research expanding on Alzheimer's treatment, regulators are constantly exercising judgments when reviewing and potentially approving new drugs.
Logan Daily News
4d
Study of Alzheimer’s drug looking for volunteers
In July of this year, the Food and Drug Administration granted traditional approval to a drug that has been found in clinical trials to slow the onset of ...
RealClearMarkets25d
The FDA Is Too Aggressive About Blocking Life-Saving Drugs
When my friend Ira was diagnosed with Pancreatic cancer he went through surgery and chemotherapy, but was still facing a short life expectancy. Then he was lucky to be 1 of only 26 patients in an ...
WXII 12 NEWS19d
Wake Forest and Duke University holding clinical trials for an FDA-approved drug to prevent Alzheimer's
ABOUT A STUDY INVOLVING AN FDA APPROVED DRUG FOR ALZHEIMER’S. THE STUDY IS CALLED AHEAD AND BOTH DUKE AND WAKE FOREST UNIVERSITIES ARE CONDUCTING CLINICAL TRIALS THAT YOU MAY BE ABLE TO JOIN.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices